By rray, 27 June, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text Initiate at least moderate intensity 30 49 LDL C lowering statin tx nbsp nbsp pitavastatin 4 mg qd AI nbsp nbsp atorvastatin 20 mg qd AII nbsp nbsp rosuvastatin 10 mg qd AII Perform further risk assessment to consider using a high intensity 50 LDL C lowering statin nbsp nbsp atorvastatin 40 80 mg qd nbsp nbsp rosuvastatin 20 40 mg qd Atorvastatin and rosuvastatin interact w ritonavir and cobicistat boosted ARVs If pregnant Defer statin tx initiation until after pregnancy in pts at low to intermediate ASCVD risk If on statin tx discontinue Breastfeeding is not recommended while on statin tx Patient Type Detail Header (Long) If HIV and 40-75 yo:<sup>3</sup>